Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy-Reference-Cited by-同舟云学术

Evolution of Experimental Models of the Liver to Predict Human Drug Hepatotoxicity and Efficacy

Published:2017-02 Issue:1 Volume:21 Page:197-214
ISSN:1089-3261
Container-title:Clinics in Liver Disease
language:en
Short-container-title:Clinics in Liver Disease

Author:

Vernetti Lawrence A.,Vogt Andreas,Gough Albert,Taylor D. Lansing

Publisher

Elsevier BV

Subject

Hepatology

Reference71 articles.

1. A perspective on implementing a quantitative systems pharmacology platform for drug discovery and the advancement of personalized medicine;Stern;J Biomol Screen,2016

2. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms. In an NIH white paper by the QSP workshop group – October, 2011;Sorger,2011

3. Pharmaceutical innovation in the 21st century: new drug approvals in the first decade, 2000-2009;Kaitin;Clin Pharmacol Ther,2011

4. How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?;Laverty;Br J Pharmacol,2011

5. Scientific and regulatory reasons for delay and denial of FDA approval of initial applications for new drugs, 2000-2012;Sacks;JAMA,2014

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of wild-type and high-risk PNPLA3 variants in a human biomimetic liver microphysiology system for metabolic dysfunction-associated steatotic liver disease precision therapy;Frontiers in Cell and Developmental Biology;2024-09-11

2. Pesticide-induced alterations in zebrafish (Danio rerio) behavior, histology, DNA damage and mRNA expression: An integrated approach;Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology;2024-06

3. Microfluidic gut-axis-on-a-chip models for pharmacokinetic-based disease models;Biomicrofluidics;2024-05-01

4. Comparison of Wild-Type and High-risk PNPLA3 variants in a Human Biomimetic Liver Microphysiology System for Metabolic Dysfunction-associated Steatotic Liver Disease Precision Therapy;2024-04-26

5. In Vitro Hepatotoxicity of Routinely Used Opioids and Sedative Drugs;Current Issues in Molecular Biology;2024-03-30